News for 'drug quality'

Indian drug makers face heat of US regulator's crackdown

Indian drug makers face heat of US regulator's crackdown

Rediff.com23 Jun 2013

Data also show that several other leading domestic pharma companies have recalled their products from the US

Does This Budget Do Enough For Health?

Does This Budget Do Enough For Health?

Rediff.com9 Feb 2023

'For free supply of drugs and medicines itself, almost Rs 20,000 crores would be required.'

Football Briefs: 'Arsenal responsible for Sanchez's missed drug test'

Football Briefs: 'Arsenal responsible for Sanchez's missed drug test'

Rediff.com26 Jan 2018

News of all that's transpired on and off the football field

Bloody Daddy Review: Big Fat Wedding Meets Gangster Gore

Bloody Daddy Review: Big Fat Wedding Meets Gangster Gore

Rediff.com9 Jun 2023

With its slick cinematography and breathless pace, Bloody Daddy is not really made for OTT, but that's where it ends up, notes Deepa Gahlot.

Budget 2023: What the pharma, healthcare industry seek

Budget 2023: What the pharma, healthcare industry seek

Rediff.com19 Jan 2023

The government should take measures to promote innovation and R&D while simplifying regulations for the sector in the upcoming Union Budget, as per pharmaceutical industry bodies. Outlining the wish list for the sector in the upcoming Union Budget, Indian Pharmaceutical Alliance (IPA) secretary general Sudarshan Jain said the domestic pharma industry is currently around $50 billion in size and aspires to grow to around $130 billion by 2030 and $450 billion by 2047. "To achieve this vision, the Union Budget 2023-2024 should help fuel innovation and R&D, which will set the pace for propelling the pharmaceutical industry forward," he told PTI.

Toxins in cough syrups, other drugs due to plastic bottling

Toxins in cough syrups, other drugs due to plastic bottling

Rediff.com1 Jun 2016

Popular antacid Mucaine Gel, manufactured by Pfizer's subsidiary Wyeth Laboratories, was also found laced with the heavy metals as well as cadmium.

10 Tips To Have A Baby After 35

10 Tips To Have A Baby After 35

Rediff.com14 Jul 2023

If you are considering pregnancy, it is advisable to meet with a healthcare provider to discuss your overall health, any pre-existing conditions, and any steps you can take to optimise your health before conceiving, advises Dr Kiran Coelho.

Junk food as bad as drugs and alcohol: Masterchef George Calombaris

Junk food as bad as drugs and alcohol: Masterchef George Calombaris

Rediff.com23 Aug 2015

Masterchef George Calombaris shares food secrets, his love for Indian cuisine and more..

India to start world's biggest vaccination drive: PM

India to start world's biggest vaccination drive: PM

Rediff.com4 Jan 2021

Lauding the scientists and technicians for the 'Made in India' vaccines, he said the country is proud of them.

Amazon fined for selling sub-standard pressure cookers

Amazon fined for selling sub-standard pressure cookers

Rediff.com4 Aug 2022

The Central Consumer Protection Authority (CCPA) has imposed a penalty of Rs 1 lakh on e-commerce major Amazon for selling pressure cookers that did not meet quality standards. The CCPA also directed Amazon to notify the consumers of all these 2,265 pressure cookers sold through its platform, recall the products and reimburse the prices to buyers, the Department of Consumer Affairs said in a statement.

9 Changes To Improve Your Sexual Health

9 Changes To Improve Your Sexual Health

Rediff.com10 Feb 2023

Don't be afraid to prioritise your sexual well-being and nurture a positive relationship with sex, suggests Maitri Trivedi.

Johnson & Johnson allowed to manufacture and sell baby powder

Johnson & Johnson allowed to manufacture and sell baby powder

Rediff.com11 Jan 2023

The Bombay high court on Wednesday permitted Johnson & Johnson to manufacture, sell and distribute its baby powder and quashed three orders of the Maharashtra government revoking the company's license and asking it to stop the product manufacture and sale, terming them as "stringent, unreasonable and unfair". A division bench of Justices Gautam Patel and S G Dige also came down heavily on the state Food and Drug Administration (FDA) for its delay in carrying out tests on a sample of the company's baby powder seized in December 2018. The bench noted that while maintaining standards of quality and safety are of utmost importance for cosmetic products, at the same time it does not seem reasonable to shut down the whole manufacturing process when there is a slight deviation in one of the products.

How To Keep Your Liver Healthy

How To Keep Your Liver Healthy

Rediff.com1 Aug 2023

Since your liver works hard to purify and detoxify your body, it is important to maintain good health of this vital organ and keep it healthy naturally, advises Dr Hansaji Yogendra.

US FDA tightens regulatory noose on Indian drug firms

US FDA tightens regulatory noose on Indian drug firms

Rediff.com17 Sep 2013

Import alert on Ranbaxy's Mohali unit; Strides' injectible arm gets warning letter

Modi hints at laws to push doctors to prescribe affordable, generic drugs

Modi hints at laws to push doctors to prescribe affordable, generic drugs

Rediff.com17 Apr 2017

These things are cheaper than equivalent branded drugs, to patients, says Modi

Aryan Khan gets Rs 4,500 money order from father

Aryan Khan gets Rs 4,500 money order from father

Rediff.com15 Oct 2021

Aryan, 23, was arrested by the Narcotics Control Bureau (NCB) on October 3 from the cruise ship off the Mumbai coast.

PE/VC investments in pharma cos cross $1 bn mark

PE/VC investments in pharma cos cross $1 bn mark

Rediff.com6 Oct 2020

Fund managers said investors remained positive on the pharma manufacturing activity in India, which further strengthened during the Covid-19 period, on account of restrictions imposed on pharma imports from China.

Key mantra for India's pharma sector in 2023

Key mantra for India's pharma sector in 2023

Rediff.com21 Dec 2022

Reinvent and innovate will be the key mantra for the Indian pharma industry in the New Year as the 'pharmacy of the world' looks to move from volume to value leadership, amid emerging challenges of inflation and pricing pressures in the global markets. While R&D investment, market competitiveness, regulatory scrutiny, and domestic price regulations are expected to shape the growth of generics and injectable products, concerns such as price control and customs duties on medical equipment will continue to bother the healthcare industry in 2023. The industry believes that in view of India's G20 Presidency, digital health innovation, achieving universal health coverage, improving healthcare infrastructure and delivery will continue to be the key driving factors in 2023.

COVID-19 Vaccine: 4 months from lab to jab

COVID-19 Vaccine: 4 months from lab to jab

Rediff.com8 Jun 2021

'Almost 70 per cent production time of a vaccine is dedicated to quality control, which is done through several hundred tests.'

PM Modi suggests 4 focus areas for Afghanistan in meeting with NSAs

PM Modi suggests 4 focus areas for Afghanistan in meeting with NSAs

Rediff.com10 Nov 2021

The need for an inclusive government in Kabul and a zero-tolerance stance on the use of Afghan territory by terrorist groups are among four aspects that Prime Minister Narendra Modi listed on Wednesday for countries in the region to focus on in the backdrop of the developments in the war-torn nation.

Sushant case: Narcotics Bureau nabs another suspect

Sushant case: Narcotics Bureau nabs another suspect

Rediff.com3 Sep 2020

The role of Rhea's brother Showik and his purported links with the people nabbed by the NCB are under the scanner of the agency and he and Rajput's manager Samuel Miranda are expected to be summoned for questioning soon, the officials said.

England rout India to reach T20 World Cup final

England rout India to reach T20 World Cup final

Rediff.com10 Nov 2022

'We came in very excited and there was a good feel around the group ... I thought everyone, from one to 11, stood up today.'

'A lot has been done between India and the US in the last two years than it was done before'

'A lot has been done between India and the US in the last two years than it was done before'

Rediff.com23 Jun 2023

'With Trump, the relationship was very transactional, whereas with President Biden it is very structured.'

When it comes to pharma, Made in Gujarat is a success story

When it comes to pharma, Made in Gujarat is a success story

Rediff.com2 Jun 2016

The percentage of non-standard quality drugs in the state has been in the range of 2-2.5% as compared to an all-India average of 5-6%

Infosys, L&T are top picks of most brokerages for Samvat 2078

Infosys, L&T are top picks of most brokerages for Samvat 2078

Rediff.com12 Nov 2021

Despite unprecedented levels of uncertainty in Samvat 2077, investors have little to complain about on the returns front. The BSE Sensex delivered returns of 38 per cent in this period, while the Nifty registered a return of over 40 per cent. As is the case in bull markets, companies in the small- and mid-capitalisation basket outperformed the benchmarks, with returns almost twice those of frontliners.

Bharat Biotech plans to supply 90 million Covaxin doses a month by Dec

Bharat Biotech plans to supply 90 million Covaxin doses a month by Dec

Rediff.com30 Sep 2021

In September, Bharat Biotech aimed to supply 35 million doses, and take this up to 55 million by October. This is still less than what the Indian government expects from the company.

Akal Takht chief says worried about spread of Christianity, Islam in Punjab

Akal Takht chief says worried about spread of Christianity, Islam in Punjab

Rediff.com6 Jun 2022

Expressing concern over the "spread of Christianity" in Punjab, Akal Takht jathedar Gyani Harpreet Singh on Monday asserted that "churches and mosques" are being built in numbers in rural parts of the state and urged Sikh preachers to visit villages to promote Sikhism.

WHO clears Serum Institute's Covovax for emergency use

WHO clears Serum Institute's Covovax for emergency use

Rediff.com18 Dec 2021

'WHO issued an emergency use listing for Covovax, expanding the basket of WHO-validated vaccines against COVID-19. The vaccine is produced by the Serum Institute of India under licence from Novavax,' the world health body said in a tweet on Friday.

FDA asks Wockhardt to conduct global assessment of its plants

FDA asks Wockhardt to conduct global assessment of its plants

Rediff.com4 Dec 2013

The FDA Commissioner Margaret Hamburg is slated to travel to India soon.

Sensex, Nifty race to over 1-week high amid global stock rally

Sensex, Nifty race to over 1-week high amid global stock rally

Rediff.com28 Dec 2021

The 30-share BSE Sensex surged by 477.24 points or 0.83 per cent to close at more than one-week high of 57,897.48. As many as 28 of its constituents closed with gains while two declined. The broad-based Nifty of the National Stock Exchange rose by 147.20 points or 0.86 per cent to settle 17,233.45, tracking gains in Sun Pharma, Asian Paints, and Reliance Industries.

PIL seeks probe into Bihar hooch tragedy; no urgent hearing, says SC

PIL seeks probe into Bihar hooch tragedy; no urgent hearing, says SC

Rediff.com16 Dec 2022

A petition has been filed in the Supreme Court, seeking an independent probe by a special investigation team (SIT) into a recent hooch tragedy in Bihar, in which at least 30 people have lost their lives.

UK's new antibody treatment against Covid may work against Omicron

UK's new antibody treatment against Covid may work against Omicron

Rediff.com2 Dec 2021

The UK's medicines regulator on Thursday approved a new antibody treatment against COVID-19, which it believes will also be effective against new variants such as Omicron.

What Tamil Nadu Does Today, India May Do Tomorrow

What Tamil Nadu Does Today, India May Do Tomorrow

Rediff.com23 Mar 2023

Tamil Nadu's latest budget offers path-breaking initiatives and major boost for social infrastructure, which other state governments are sure to follow in the coming years, predicts N Sathiya Moorthy.

WHO meet next week to discuss Covaxin approval

WHO meet next week to discuss Covaxin approval

Rediff.com18 Oct 2021

The World Health Organisation's technical advisory group will meet on October 26 to consider the Emergency Use Listing (EUL) of Covaxin, a vaccine developed by Hyderabad-based Bharat Biotech protecting against COVID-19, the global health agency's chief scientist said.

Novovax Covid vaccine likely to get nod in India ahead of US

Novovax Covid vaccine likely to get nod in India ahead of US

Rediff.com18 Aug 2021

Adar Poonawalla said he was hopeful that Covovax, the Novavax vaccine made by SII, will be launched around October this year for adults and for children by the first quarter of next year, depending on DCGI approvals.

Covid vaccine: Pharma firms ready expansion plans

Covid vaccine: Pharma firms ready expansion plans

Rediff.com6 Oct 2020

The Indian vaccine industry largely feels there are two ways in which vaccine innovation can be spurred - one, get a high price for the product and two, have the government buy a few hundred million doses of the product at a certain price.

Biological E plans to make 100m Corbevax jabs per month from Feb 2022

Biological E plans to make 100m Corbevax jabs per month from Feb 2022

Rediff.com28 Dec 2021

Biological E Limited plans to complete production at a rate of 75 million doses of its COVID-19 vaccine Corbevax per month, anticipating over 100 million doses per month from February 2022 which will enable the Hyderabad-based company to deliver 300 Million doses as promised to the Centre, BE said on Tuesday.

Why Doctors Stopped Being Gods

Why Doctors Stopped Being Gods

Rediff.com15 Sep 2022

I got to know that every referred case for angiography and angioplasty got a kickback of Rs 5,000 and Rs 15,000 respectively. Seeing this trend, doctors started paying referring doctors Rs 1 lakh in advance and adjusting it as and when patients came in. This menace slowly spread its tentacles all over the medical field, including radiological diagnostics and biochemistry laboratories. For every test ordered, 20 per cent of the bill was given back to the referring doctor. This led to doctors recommending unnecessary tests. The pharmaceutical companies also saw burgeoning business. Acclaimed doctors were given televisions sets, refrigerators, air conditioners and cars depending upon the prescriptions. General practitioners would prescribe unnecessary drugs, and were given returns in cash. A fascinating excerpt from Dr Upendra Kaul's When The Heart Speaks.

Kuttey Review: Who Let The Dogs Out?

Kuttey Review: Who Let The Dogs Out?

Rediff.com13 Jan 2023

Kuttey's muddled momentum cannot cover up the trail of loopholes it leaves behind, observes Sukanya Verma.

Parl panel advises caution in emergency approval of vaccine

Parl panel advises caution in emergency approval of vaccine

Rediff.com21 Dec 2020

In a report submitted Monday to Rajya Sabha chairman and Vice President M Venkaiah Naidu, the Parliamentary Standing Committee on Home Affairs also said there was a need for a comprehensive public health law to keep a tab on private hospitals and check black-marketing of medicines.